Top experts by indication / Oncology
Most active experts in Carcinoma, Squamous Cell
2026 edition, data as of October 27, 2026
240 key opinion leaders in the directory are tagged to Carcinoma, Squamous Cell. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 240 of the 240 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Douglas AdkinsWashington University School of Medicine in St. Louis, MO | 21 trials |
| 2 | Dan ZandbergMD | 12 trials |
| 3 | Glenn HannaDana Farber Cancer Institute, MA | 10 trials |
| 4 | Tanguy SeiwertJohns Hopkins University School of Medicine, MD | 10 trials |
| 5 | Nabil SabaEmory University, GA | 9 trials |
| 6 | Christine ChungMoffitt Cancer Center, FL | 9 trials |
| 7 | Anurag SinghNY | 8 trials |
| 8 | Renata FerrarottoThe University of Texas MD Anderson Cancer Center, TX | 8 trials |
| 9 | Ari RosenbergUniversity of Chicago, IL | 7 trials |
| 10 | Julie BaumanGeorge Washington University School of Medicine and Health Sciences, DC | 7 trials |
| 11 | Barbara BurtnessYale School of Medicine, CT | 6 trials |
| 12 | Susanne ArnoldUniversity of Kentucky, KY | 6 trials |
| 13 | Stuart WongMedical College of Wisconsin, WI | 6 trials |
| 14 | Everett VokesUniversity of Chicago, IL | 5 trials |
| 15 | Paul SwiecickiUniversity of Michigan, MI | 5 trials |
| 16 | Marshall PosnerFL | 5 trials |
| 17 | Nancy LeeNY | 4 trials |
| 18 | Cathy EngVanderbilt University Medical Center, TN | 4 trials |
| 19 | Justine BruceUniversity of Wisconsin–Madison, WI | 4 trials |
| 20 | Jared WeissUniversity of North Carolina at Chapel Hill, NC | 4 trials |
| 21 | Francis WordenUniversity of Michigan, MI | 4 trials |
| 22 | Maura GillisonThe University of Texas MD Anderson Cancer Center, TX | 4 trials |
| 23 | Charalampos FloudasNational Institutes of Health, MD | 3 trials |
| 24 | Ashley WardCA | 3 trials |
| 25 | Vassiliki SalouraIL | 3 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 54 of the 240 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Everett VokesUniversity of Chicago, IL | 80,021 citations |
| 2 | Maura GillisonThe University of Texas MD Anderson Cancer Center, TX | 60,454 citations |
| 3 | Eric ChenUniversity of Hong Kong, TX | 52,043 citations |
| 4 | David HongThe University of Texas MD Anderson Cancer Center, TX | 47,734 citations |
| 5 | Kathleen MooreUniversity of Nebraska Medical Center, OK | 47,487 citations |
| 6 | Bradley MonkFlorida Cancer Specialists & Research Institute, FL | 45,442 citations |
| 7 | Yi LinMayo Clinic, MN | 40,137 citations |
| 8 | Joel PalefskyUniversity of California, San Francisco, CA | 39,245 citations |
| 9 | Neal ReadyDuke University School of Medicine, NC | 32,845 citations |
| 10 | Christine ChungMoffitt Cancer Center, FL | 28,625 citations |
| 11 | Cathy EngVanderbilt University Medical Center, TN | 26,943 citations |
| 12 | Paul HarariUniversity of Wisconsin-Madison School of Medicine and Public Health, WI | 26,351 citations |
| 13 | Michael GoldGold Skin Care Center, TN | 25,864 citations |
| 14 | Tanguy SeiwertJohns Hopkins University School of Medicine, MD | 23,345 citations |
| 15 | Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA | 22,591 citations |
| 16 | Francis WordenUniversity of Michigan, MI | 22,578 citations |
| 17 | Nabil SabaEmory University, GA | 22,402 citations |
| 18 | Evan LipsonJohns Hopkins University School of Medicine, MD | 22,120 citations |
| 19 | William CarsonThe Ohio State University, OH | 20,951 citations |
| 20 | Carole FakhryJohns Hopkins University School of Medicine, MD | 20,606 citations |
| 21 | Paul PaikMemorial Sloan Kettering Cancer Center, NY | 19,030 citations |
| 22 | Sue YomUniversity of California, San Francisco, CA | 18,553 citations |
| 23 | Brendan CurtiProvidence Cancer Institute, OR | 16,220 citations |
| 24 | Nikhil KhushalaniMoffitt Cancer Center, NY | 15,285 citations |
| 25 | Douglas AdkinsWashington University School of Medicine in St. Louis, MO | 14,605 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 43 of the 240 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Joel PalefskyUniversity of California, San Francisco, CA | 21 awards |
| 2 | William CarsonThe Ohio State University, OH | 19 awards |
| 3 | Kathleen SchmelerThe University of Texas MD Anderson Cancer Center, TX | 7 awards |
| 4 | Evan GraboyesMedical University of South Carolina, SC | 7 awards |
| 5 | Kathleen MooreUniversity of Nebraska Medical Center, OK | 6 awards |
| 6 | Paul HarariUniversity of Wisconsin-Madison School of Medicine and Public Health, WI | 6 awards |
| 7 | Everett VokesUniversity of Chicago, IL | 5 awards |
| 8 | Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA | 5 awards |
| 9 | Yi LinMayo Clinic, MN | 5 awards |
| 10 | Barbara BurtnessYale School of Medicine, CT | 4 awards |
| 11 | Alexander LinPA | 4 awards |
| 12 | Faye JohnsonTX | 4 awards |
| 13 | David HongThe University of Texas MD Anderson Cancer Center, TX | 4 awards |
| 14 | Brendan CurtiProvidence Cancer Institute, OR | 4 awards |
| 15 | Stuart WongMedical College of Wisconsin, WI | 4 awards |
| 16 | Nancy LeeNY | 3 awards |
| 17 | Anurag SinghNY | 3 awards |
| 18 | Charles LeathUniversity of Alabama at Birmingham, AL | 3 awards |
| 19 | Nabil SabaEmory University, GA | 3 awards |
| 20 | Christine ChungMoffitt Cancer Center, FL | 3 awards |
| 21 | Sue YomUniversity of California, San Francisco, CA | 2 awards |
| 22 | Renata FerrarottoThe University of Texas MD Anderson Cancer Center, TX | 2 awards |
| 23 | Cathy EngVanderbilt University Medical Center, TN | 2 awards |
| 24 | Carole FakhryJohns Hopkins University School of Medicine, MD | 2 awards |
| 25 | Susanne ArnoldUniversity of Kentucky, KY | 2 awards |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 34 of the 240 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Anthony El-KhoueiryUSC Norris Comprehensive Cancer Center, CA | 275 contributions |
| 2 | Cathy EngVanderbilt University Medical Center, TN | 240 contributions |
| 3 | Yi LinMayo Clinic, MN | 226 contributions |
| 4 | Kanwal RaghavThe University of Texas MD Anderson Cancer Center, TX | 191 contributions |
| 5 | Shlomo KoyfmanCleveland Clinic, OH | 164 contributions |
| 6 | Paul HarariUniversity of Wisconsin-Madison School of Medicine and Public Health, WI | 142 contributions |
| 7 | Tanguy SeiwertJohns Hopkins University School of Medicine, MD | 138 contributions |
| 8 | Christine ChungMoffitt Cancer Center, FL | 116 contributions |
| 9 | Nikhil KhushalaniMoffitt Cancer Center, NY | 115 contributions |
| 10 | Francis WordenUniversity of Michigan, MI | 111 contributions |
| 11 | Douglas AdkinsWashington University School of Medicine in St. Louis, MO | 102 contributions |
| 12 | Glenn HannaDana Farber Cancer Institute, MA | 98 contributions |
| 13 | Susanne ArnoldUniversity of Kentucky, KY | 91 contributions |
| 14 | Paul PaikMemorial Sloan Kettering Cancer Center, NY | 84 contributions |
| 15 | Renata FerrarottoThe University of Texas MD Anderson Cancer Center, TX | 79 contributions |
| 16 | Maura GillisonThe University of Texas MD Anderson Cancer Center, TX | 79 contributions |
| 17 | Roxana DroncaMayo Clinic, FL | 70 contributions |
| 18 | William CarsonThe Ohio State University, OH | 69 contributions |
| 19 | Colette ShenUniversity of North Carolina at Chapel Hill, NC | 66 contributions |
| 20 | Neal ReadyDuke University School of Medicine, NC | 65 contributions |
| 21 | Stuart WongMedical College of Wisconsin, WI | 62 contributions |
| 22 | Julie BaumanGeorge Washington University School of Medicine and Health Sciences, DC | 60 contributions |
| 23 | Linda DuskaUniversity of Virginia Health System, VA | 60 contributions |
| 24 | Jyoti MayadevUniversity of California, San Diego, CA | 57 contributions |
| 25 | Justine BruceUniversity of Wisconsin–Madison, WI | 49 contributions |
Emerging
13 of the 240 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Stephane ChampiatThe University of Texas MD Anderson Cancer Center, TX |
| Cathy EngVanderbilt University Medical Center, TN |
| Maura GillisonThe University of Texas MD Anderson Cancer Center, TX |
| Yelena JanjigianMemorial Sloan Kettering Cancer Center, NY |
| Evan LipsonJohns Hopkins University School of Medicine, MD |
| Wells MessersmithUniversity of Colorado Cancer Center, CO |
| Michael PishvaianJohns Hopkins University School of Medicine, DC |
| Alessandro SantinYale School of Medicine, CT |
| Jonathan SchoenfeldBrigham and Women's Hospital, MA |
| Heath SkinnerUniversity of Pittsburgh, PA |
| Paul SwiecickiUniversity of Michigan, MI |
| Apostolia TsimberidouThe University of Texas MD Anderson Cancer Center, TX |
| Jesse ZaretskyMO |
How these tables are computed
The cohort is every profile in the directory tagged to Carcinoma, Squamous Cell, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Carcinoma, Squamous Cell profile in the directory